254 related articles for article (PubMed ID: 25388424)
1. Grading and interpretation of white matter hyperintensities using statistical maps.
Ryu WS; Woo SH; Schellingerhout D; Chung MK; Kim CK; Jang MU; Park KJ; Hong KS; Jeong SW; Na JY; Cho KH; Kim JT; Kim BJ; Han MK; Lee J; Cha JK; Kim DH; Lee SJ; Ko Y; Cho YJ; Lee BC; Yu KH; Oh MS; Park JM; Kang K; Lee KB; Park TH; Lee J; Choi HK; Lee K; Bae HJ; Kim DE
Stroke; 2014 Dec; 45(12):3567-75. PubMed ID: 25388424
[TBL] [Abstract][Full Text] [Related]
2. Periodic Limb Movements and White Matter Hyperintensities in First-Ever Minor Stroke or High-Risk Transient Ischemic Attack.
Boulos MI; Murray BJ; Muir RT; Gao F; Szilagyi GM; Huroy M; Kiss A; Walters AS; Black SE; Lim AS; Swartz RH
Sleep; 2017 Mar; 40(3):. PubMed ID: 28329254
[TBL] [Abstract][Full Text] [Related]
3. Association of intracranial atherosclerotic stenosis with severity of white matter hyperintensities.
Park JH; Kwon HM; Lee J; Kim DS; Ovbiagele B
Eur J Neurol; 2015 Jan; 22(1):44-52, e2-3. PubMed ID: 24712717
[TBL] [Abstract][Full Text] [Related]
4. Reduced blood flow in normal white matter predicts development of leukoaraiosis.
Bernbaum M; Menon BK; Fick G; Smith EE; Goyal M; Frayne R; Coutts SB
J Cereb Blood Flow Metab; 2015 Oct; 35(10):1610-5. PubMed ID: 25966951
[TBL] [Abstract][Full Text] [Related]
5. Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset.
Zhang CR; Cloonan L; Fitzpatrick KM; Kanakis AS; Ayres AM; Furie KL; Rosand J; Rost NS
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):649-54. PubMed ID: 25576348
[TBL] [Abstract][Full Text] [Related]
6. Brainstem leukoaraiosis independently predicts poor outcome after ischemic stroke.
Giralt-Steinhauer E; Medrano S; Soriano-Tárraga C; Mola-Caminal M; Rasal R; Cuadrado-Godia E; Rodríguez-Campello A; Ois A; Capellades J; Jimenez-Conde J; Roquer J
Eur J Neurol; 2018 Aug; 25(8):1086-1092. PubMed ID: 29660221
[TBL] [Abstract][Full Text] [Related]
7. Long-term progression of white matter hyperintensities in ischemic stroke.
Holmegaard L; Jensen C; Redfors P; Blomstrand C; Jern C; Jood K
Acta Neurol Scand; 2018 Dec; 138(6):548-556. PubMed ID: 30152523
[TBL] [Abstract][Full Text] [Related]
8. White Matter Hyperintensity-Adjusted Critical Infarct Thresholds to Predict a Favorable 90-Day Outcome.
Patti J; Helenius J; Puri AS; Henninger N
Stroke; 2016 Oct; 47(10):2526-33. PubMed ID: 27633020
[TBL] [Abstract][Full Text] [Related]
9. Cerebral white matter hyperintensities (WMH): an analysis of cerebrovascular risk factors in Lebanon.
Gebeily S; Fares Y; Kordahi M; Khodeir P; Labaki G; Fazekas F
Int J Neurosci; 2014 Nov; 124(11):799-805. PubMed ID: 24433122
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of white matter hyperintensities on long-term outcomes in ischemic stroke patients with large artery atherosclerosis.
Baik M; Kim K; Yoo J; Kim HC; Jeong SH; Kim KH; Park HJ; Kim YD; Heo JH; Nam HS
PLoS One; 2017; 12(12):e0189611. PubMed ID: 29232701
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation is associated with anterior predominant white matter lesions in patients presenting with embolic stroke.
Mayasi Y; Helenius J; McManus DD; Goddeau RP; Jun-O'Connell AH; Moonis M; Henninger N
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):6-13. PubMed ID: 28554961
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the Association Between Corticospinal Tract Damage and Outcome After Stroke by White Matter Hyperintensities.
Ferris JK; Lo BP; Barisano G; Brodtmann A; Buetefisch CM; Conforto AB; Donnelly MR; Egorova-Brumley N; Hayward KS; Khlif MS; Revill KP; Zavaliangos-Petropulu A; Boyd L; Liew SL
Neurology; 2024 May; 102(10):e209387. PubMed ID: 38701386
[TBL] [Abstract][Full Text] [Related]
13. Age and recurrent stroke are related to the severity of white matter hyperintensities in lacunar infarction patients with diabetes.
Yu L; Yang L; Zhang X; Yuan J; Li Y; Yang S; Gu H; Hu W; Gao S
Clin Interv Aging; 2018; 13():2487-2494. PubMed ID: 30584289
[TBL] [Abstract][Full Text] [Related]
14. Association of deep white matter hyperintensity with left ventricular hypertrophy in acute ischemic stroke.
Nagaraja N; Farooqui A; Albayram MS
J Neuroimaging; 2022 Mar; 32(2):268-272. PubMed ID: 34861077
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
[TBL] [Abstract][Full Text] [Related]
16. Progression of white matter hyperintensities of presumed vascular origin increases the risk of falls in older people.
Callisaya ML; Beare R; Phan T; Blizzard L; Thrift AG; Chen J; Srikanth VK
J Gerontol A Biol Sci Med Sci; 2015 Mar; 70(3):360-6. PubMed ID: 25199911
[TBL] [Abstract][Full Text] [Related]
17. Volumetric analyses of cerebral white matter hyperintensity lesions on magnetic resonance imaging in a Japanese population undergoing medical check-up.
Honda Y; Noguchi A; Maruyama K; Tamura A; Saito I; Sei K; Soga T; Ushiba K; Hirano T; Sakurai T; Shiokawa Y
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():43-7. PubMed ID: 26671156
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the serum eicosapentanoic acid-to-arachidonic acid ratio and the severity of cerebral white matter hyperintensities in older adults with memory disorder.
Nagai K; Koshiba H; Shibata S; Matsui T; Kozaki K
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():48-52. PubMed ID: 26671157
[TBL] [Abstract][Full Text] [Related]
19. Metric to quantify white matter damage on brain magnetic resonance images.
Valdés Hernández MDC; Chappell FM; Muñoz Maniega S; Dickie DA; Royle NA; Morris Z; Anblagan D; Sakka E; Armitage PA; Bastin ME; Deary IJ; Wardlaw JM
Neuroradiology; 2017 Oct; 59(10):951-962. PubMed ID: 28815362
[TBL] [Abstract][Full Text] [Related]
20. Association of Stroke Lesion Pattern and White Matter Hyperintensity Burden With Stroke Severity and Outcome.
Bonkhoff AK; Hong S; Bretzner M; Schirmer MD; Regenhardt RW; Arsava EM; Donahue K; Nardin M; Dalca A; Giese AK; Etherton MR; Hancock BL; Mocking SJT; McIntosh E; Attia J; Benavente O; Cole JW; Donatti A; Griessenauer C; Heitsch L; Holmegaard L; Jood K; Jimenez-Conde J; Kittner S; Lemmens R; Levi C; McDonough CW; Meschia J; Phuah CL; Rolfs A; Ropele S; Rosand J; Roquer J; Rundek T; Sacco RL; Schmidt R; Sharma P; Slowik A; Soederholm M; Sousa A; Stanne TM; Strbian D; Tatlisumak T; Thijs V; Vagal A; Wasselius J; Woo D; Zand R; McArdle P; Worrall BB; Jern C; Lindgren AG; Maguire J; Golland P; Bzdok D; Wu O; Rost NS
Neurology; 2022 Sep; 99(13):e1364-e1379. PubMed ID: 35803717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
